Product Program year 2021 Source: CMS Open Payments

Gloperba

Drug Prophylaxis of gout flares in adults

NDC 75854-801-01

Open in the dashboard

General payments

$22,459

16 payments

Research payments

$0

0 payments

Through program year 2021, $22,459 in general payments and $0 in research payments were reported against Gloperba (Prophylaxis of gout flares in adults).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $5,313 6
2020 General $17,147 10

Breakdown

Who paid General payments · program years 2020–2021
  1. Avion Pharmaceuticals $22,459 16 payments
Top recipients General payments · program year 2021
  1. Alvin Wells Rheumatology · Destin, FL $2,300 43% · 1 payment
  2. Eric Matheson Family Medicine · Charleston, SC $1,035 19% · 1 payment
  3. Richard Wilkes Family Medicine · Mt Pleasant, SC $900 17% · 1 payment
  4. Claudia Rivera-Salas Nurse Practitioner · East Lansing, MI $600 11% · 1 payment
  5. Amanda Mixon Physician Assistant, Medical · Fort Collins, CO $465 9% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Rheumatology Internal Medicine $2,300 43% · 1 practitioner
  2. Family Medicine $1,935 36% · 2 practitioners
  3. Nurse Practitioner $600 11% · 1 practitioner
  4. Physician Assistant, Medical Physician Assistant $465 9% · 1 practitioner
  5. Internal Medicine $13 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. Illinois $2,300 43% · 1 recipient
  2. South Carolina $1,935 36% · 2 recipients
  3. Michigan $600 11% · 1 recipient
  4. Colorado $465 9% · 1 recipient
  5. Maryland $13 <1% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

16 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record